BET-Inhibitor I-BET762 and PARP-Inhibitor Talazoparib Synergy in Small Cell Lung Cancer Cells
- Supplementary File 1:
ZIP-Document (ZIP, 3506 KiB)
Fiorentino, F.P.; Marchesi, I.; Schröder, C.; Schmidt, R.; Yokota, J.; Bagella, L. BET-Inhibitor I-BET762 and PARP-Inhibitor Talazoparib Synergy in Small Cell Lung Cancer Cells. Int. J. Mol. Sci. 2020, 21, 9595. https://doi.org/10.3390/ijms21249595
Fiorentino FP, Marchesi I, Schröder C, Schmidt R, Yokota J, Bagella L. BET-Inhibitor I-BET762 and PARP-Inhibitor Talazoparib Synergy in Small Cell Lung Cancer Cells. International Journal of Molecular Sciences. 2020; 21(24):9595. https://doi.org/10.3390/ijms21249595
Chicago/Turabian StyleFiorentino, Francesco Paolo, Irene Marchesi, Christoph Schröder, Ronny Schmidt, Jun Yokota, and Luigi Bagella. 2020. "BET-Inhibitor I-BET762 and PARP-Inhibitor Talazoparib Synergy in Small Cell Lung Cancer Cells" International Journal of Molecular Sciences 21, no. 24: 9595. https://doi.org/10.3390/ijms21249595